arrow
Back
A

Arijit Chakravarty

fractal therapeutics, lexington, ma, usa

23H-index
192Paper Count
1.8KCitation Count
Published Papers 55
Publication Date
A novel approach for first-in-human dose selection using population dose-response modelling to find a minimum anticipated biological effect level
err2025-04-27
err0
PREAI
errLin Yuan; Meghana Kulkarni; Evan Chiswick; Cheryl Koh; Peter Sandy; Salah Nabhan; Woody Sherman; Melissa Johnson; Judy Wang; Gerald Falchook; Jennifer Johnson; Christopher Winter; Humphrey Gardner; Arijit Chakravarty; Madison Stoddard
errShare
errSave
The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis
err2025-03-30
err0
errOAAI
errYuan, Lin; Stoddard, Madison; Sarkar, Sharanya; van Egeren, Debra; Mangalaganesh, Shruthi; Nolan, Ryan P.; Rogers, Michael S.; Hather, Greg; White, Laura F.; Chakravarty, Arijit
errShare
errSave
Can we do better with Mylotarg? Model-based assessment of opportunities to improve therapeutic index
err2024-09-01
err0
PREAI
errStoddard, Madison; Yuan, Lin; Cooper, Jodi; Neumar, Christine Carcillo; Hibner, Barbara; Gardner, Humphrey; Chakravarty, Arijit
errShare
errSave
Impact of drug combination schedules on the evolution of tumor resistance
err2024-03-22
err0
PREAI
errStoddard, Madison; Chen, Andrew; Yuan, Lin; Van Egeren, Debra; Bottino, Dean; Chakravarty, Arijit
errShare
errSave
Using game theory to investigate the therapeutic potential of disrupting tumor-microenvironment interactions
err2024-03-22
err0
PREAI
errVan Egeren, Debra; Chen, Andrew; Stoddard, Madison; Yuan, Lin; Chakravarty, Arijit
errShare
errSave
Understanding three-drug combinations: optimizing scheduling while avoiding toxicity
err2024-03-22
err0
PREAI
errStoddard, Madison; Yuan, Lin; Van Egeren, Debra; Chen, Andrew; Bottino, Dean; Chakravarty, Arijit
errShare
errSave
Model-derived progression-free survival (mPFS): A better metric for patient-derived xenograft studies
err2024-03-22
err0
PREAI
errChen, Andrew; Stoddard, Madison; Yuan, Lin; Van Egeren, Debra; Chakravarty, Arijit; Bottino, Dean
errShare
errSave
Blood brain barrier masks effects of dosing strategy
err2024-03-22
err0
PREAI
errStoddard, Madison; Chen, Andrew; Yuan, Lin; Van Egeren, Debra; Chakravarty, Arijit
errShare
errSave
Towards better prediction of treatment resistance: Directly modeling progression from multiple lesions
err2024-03-22
err0
PREAI
errProtich, Samuel; Stoddard, Madison; Yuan, Lin; White, Douglas; Bottino, Dean; Chakravarty, Arijit
errShare
errSave
Looking under the lamp-post: quantifying the performance of contact tracing in the United States during the SARS-CoV-2 pandemic
err2024-02-23
err0
errOAAI
errBayly, Henry; Stoddard, Madison; Van Egeren, Debra; Murray, Eleanor J.; Raifman, Julia; Chakravarty, Arijit; White, Laura F.
errShare
errSave
Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2
err2023-04-16
err10
errOAAI
errVan Egeren, Debra; Stoddard, Madison; White, Laura F.; Hochberg, Natasha S.; Rogers, Michael S.; Zetter, Bruce; Joseph-McCarthy, Diane; Chakravarty, Arijit
errShare
errSave
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy
err2023-04-06
err3
errOAAI
errStoddard, Madison; Yuan, Lin; Sarkar, Sharanya; Mangalaganesh, Shruthi; Nolan, Ryan P.; Bottino, Dean; Hather, Greg; Hochberg, Natasha S.; White, Laura F.; Chakravarty, Arijit
errShare
errSave
MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy
err2023-03-27
err214
errOAAI
errHoar, Kara; Chakravarty, Arijit; Rabino, Claudia; Wysong, Deborah; Bowman, Douglas; Roy, Natalie; Ecsedy, Jeffrey A.
errShare
errSave
No magic bullet: Limiting in-school transmission in the face of variable SARS-CoV-2 viral loads
err2022-12-01
err3
errOAAI
errVan Egeren, Debra; Stoddard, Madison; Malakar, Abir; Ghosh, Debayan; Acharya, Antu; Mainuddin, Sk; Majumdar, Biswajit; Luo, Deborah; Nolan, Ryan P.; Joseph-McCarthy, Diane; White, Laura F.; Hochberg, Natasha S.; Basu, Saikat; Chakravarty, Arijit
errShare
errSave
The role of schools in driving SARS-CoV-2 transmission: Not just an open-and-shut case
err2022-03-01
err14
errOAAI
errWhite, Laura F.; Murray, Eleanor J.; Chakravarty, Arijit
errShare
errSave
Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure
err2021-11-19
err10
errOAAI
errVan Egeren, Debra; Novokhodko, Alexander; Stoddard, Madison; Tran, Uyen; Zetter, Bruce; Rogers, Michael S.; Joseph-McCarthy, Diane; Chakravarty, Arijit
errShare
errSave
Individually optimal choices can be collectively disastrous in COVID-19 disease control
err2021-04-30
err13
errOAAI
errStoddard, Madison; Van Egeren, Debra; Johnson, Kaitlyn E.; Rao, Smriti; Furgeson, Josh; White, Douglas E.; Nolan, Ryan P.; Hochberg, Natasha; Chakravarty, Arijit
errShare
errSave
Dose Optimization for Anticancer Drug Combinations: Maximizing Therapeutic Index via Clinical Exposure-Toxicity/Preclinical Exposure-Efficacy Modeling
err2019-11-15
err22
errOAAI
errBottino, Dean C.; Patel, Mayankbhai; Kadakia, Ekta; Zhou, Jilai; Patel, Chirag; Neuwirth, Rachel; Iartchouk, Natasha; Brake, Rachael; Venkatakrishnan, Karthik; Chakravarty, Arijit
errShare
errSave
In vivo activities of TP-2846: a novel tetracycline antileukemia agent
err2019-07-01
err1
PREAI
errXiao, Xiao-Yi; Sun, Cuixiang; Zhou, Jian; Tatsuta, Noriaki; Newman, Joseph; White, Douglas; Hibner, Barbara; Chakravarty, Arijit; Dumas, Jacques
errShare
errSave